| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |